Page last updated: 2024-08-23

cefotiam and Bacterial Pneumonia

cefotiam has been researched along with Bacterial Pneumonia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banks, SM; Cui, X; Eichacker, PQ; Gerstenberger, E; Hartung, T; Karzai, W; Mehlhorn, B; Natanson, C; Reinhart, K; Straube, E1
Bando, T; Chiba, S; Hiraga, Y; Hirai, Y; Inoue, H; Ito, T; Kikuchi, K; Kobayashi, H; Matsumoto, H; Moriya, K; Mouri, T; Nakashima, M; Ohmichi, M; Ohsaki, Y; Saito, A; Sakamoto, M; Sasaki, N; Shirato, K; Suda, T; Takeuchi, K; Tanifuji, Y; Tanno, Y; Tsuzino, M; Yoshida, M1
Chifu, S; Ebihara, M; Fukunaga, H; Furuno, T; Genka, K; Harada, Y; Hiraoka, T; Hirota, N; Inuyama, M; Ishibashi, T; Iwanaga, T; Kisanuki, K; Kishikawa, R; Makie, T; Matsukizono, K; Matsuura, Y; Mitsuno, T; Namba, K; Oe, T; Shimazu, K; Sugiyama, M; Takamoto, M; Tsumori, Y; Tsurutani, H; Ueno, Y1

Trials

2 trial(s) available for cefotiam and Bacterial Pneumonia

ArticleYear
[A comparative study on the efficacies of ritipenem acoxil and cefotiam hexetil in bacterial pneumonia by the double-blind method].
    The Japanese journal of antibiotics, 1996, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Carbapenems; Cefotiam; Double-Blind Method; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prodrugs

1996
[Clinical efficacy of sulbactam/ampicillin in comparison with cefotiam in the treatment of elderly patients with pneumonia].
    The Japanese journal of antibiotics, 1998, Volume: 51, Issue:12

    Topics: Aged; Aged, 80 and over; Alanine Transaminase; Ampicillin; Aspartate Aminotransferases; Cefotiam; Cephalosporins; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Pneumonia, Bacterial; Sulbactam; Treatment Outcome

1998

Other Studies

1 other study(ies) available for cefotiam and Bacterial Pneumonia

ArticleYear
Protection with antibody to tumor necrosis factor differs with similarly lethal Escherichia coli versus Staphylococcus aureus pneumonia in rats.
    Anesthesiology, 2003, Volume: 99, Issue:1

    Topics: Administration, Inhalation; Animals; Antibodies; Bronchoalveolar Lavage Fluid; Cefotiam; Cephalosporins; Escherichia coli; Escherichia coli Infections; Injections, Intraperitoneal; Interleukin-6; Intubation, Intratracheal; Leukocyte Count; Lymphocyte Count; Male; Neutrophils; Oxygen; Oxygen Consumption; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Rats; Rats, Wistar; Sepsis; Staphylococcus aureus; Survival Analysis; Tumor Necrosis Factor-alpha

2003